The latest in patent news for the biotech and biology industries
The following stories related to patents in biotech and biological sciences are provided by Integrity IP in conjunction with various cooperating internet news sources. Please enjoy these news feeds to find the most current news in your fields of interest.
-
Reportlinker.com announces that a new market research report is available in its catalogue:
Proteomics: Technologies and Global Markets
http://www.reportlinker.com/p0132719/Proteomics-Technologies-and-Global-Markets.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics
STUDY...
-
CAO Group, Inc. (CAO), a world leading, high-tech dental company, refutes lawsuit claims by Procter & Gamble (NYSE: PG) and affirms that the advanced technology applied to its treatment film products, including Sheer White®, Sheer DesenZ® and Sheer FluorX® for teeth whitening,...
-
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include Actavis, Inc.'s (NYSE:ACT), BP plc (NYSE:BP), Total SA...
-
Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets and Technologies for Optical Coherence Tomography (OCT) – Focus on Time Domain and Polarization...
-
Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets and Technologies for Optical Coherence Tomography (OCT) – Focus on Full Field and Optical...
-
Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets and Technologies for Optical Coherence Tomography (OCT) – Focus on Fourier Domain and Time...
-
Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets and Technologies for Optical Coherence Tomography...
-
Reportlinker.com announces that a new market research report is available in its catalogue:
Global Markets for Infectious Disease...
-
U.S. spending on specialty prescription drugs — those used to treat chronic, complex diseases such as cancer, multiple sclerosis and rheumatoid arthritis — is projected to increase 67 percent by the end of 2015, according to a forecast released today by Express Scripts (NASDAQ: ESRX)....
-
Mylan Inc. (Nasdaq: MYL) today announced that the Court of Appeals for the Federal Circuit has ruled in favor of Mylan Specialty L.P., f/k/a Dey Pharma, L.P. and has reversed the District Court's decision invalidating five of Mylan's patents related to Perforomist®. The Court's reversal of...
-
Complix, a biopharmaceutical company focused on the discovery and development of Alphabodies™, a unique class of protein therapeutics that are active against intracellular disease targets, announces that its CEO Dr Mark Vaeck will present at BioEquity Europe 2013 in Stockholm, Sweden (May...
-
Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively "OrbusNeich") today announced that it has enforced the seizure of over 190 stent systems from Boston Scientific Corporation (NYSE: BSX) in connection with its patent infringement...
-
Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced that it will demonstrate the Verrata™ Pressure Guide Wire and the...
-
Royal Philips Electronics (NYSE: PHG, AEX: PHIA) today announced that CX50 xMATRIX, the world's first portable ultrasound with Philips' industry leading Live 3D TEE, now offers 2-D Intracardiac Echo (ICE) capability. The CX50 xMATRIX with available Live 3D TEE and ICE will be shown in Paris at the...
-
Volcano Corporation (NASDAQ: VOLC) a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, today announced it will highlight its efforts to expand research and innovation surrounding...
-
Recondo Technology announced today that Recondo® has been named by Healthcare Informatics as one of the Top 100 healthcare Information Technology (IT) companies in the United States. This is the first appearance for Recondo in the list, ranked at Number 97.
(Logo: ...
-
MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has secured a revolving line of credit with Bank of America. The revolving...
-
Echo Pharma Acquisition Limited ("Royalty Pharma") today announced, pursuant to Rule 2.5 of the Irish Takeover Rules (the "Announcement"), a firm intention to increase its offer for Elan Corporation, plc (NYSE: ELN) to $12.50 per share in cash. The increased offer is fully financed,...
-
Tomophase Corporation, a leading developer of minimally invasive optical coherence tomography (OCT) tissue imaging devices, announced today that the Thoraxklinik at the University of Heidelberg, Germany has taken the first OCTIS images in clinical patients with the Tomophase OCT Imaging...
-
Rosetta Genomics Ltd. (NASDAQ: ROSG), a leading developer and provider of microRNA-based molecular diagnostics, announces that the Company has executed a credentialing agreement with Prime Health Services, Inc. (Prime Health), a managed care company that offers a full spectrum of services,...